Psoriasin

Manufacturer
Alva-Amco Pharmacal Companies, Inc.
Effective date
2010-05-07
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:24:26

Label at a glance#

ProductPsoriasin Therapeutic Shampoo and Body Wash
Active ingredientSalicylic acid
Label structure13 sections

Indications and uses

For the relief of symptoms associated with psoriasis and/or seborrheic dermatitis including itching, flaking, redness and irritation of the skin and scalp.  Helps prevent recurrence.

Dosage and administration

Read all package directions and warnings before use and use only as directed. For best results, use at least two times per week or as recommended by a doctor. Use on affected areas in place of regular soap or shampoo. Wet skin and/or scalp. Apply Psoriasin Therapeutic Shampoo and Body Wash and massage to form a rich lather. Leave lather on the scalp for two minutes. Rinse thoroughly. Repeat if necessary. Intended ...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid, 3%..................................Psoriasis/Seborrheic Dermatitis Treatment

Uses

OTC - PURPOSE SECTION

For the relief of symptoms associated with psoriasis and/or seborrheic dermatitis including itching, flaking, redness and irritation of the skin and scalp.  Helps prevent recurrence.

Warnings

WARNINGS SECTION

For external use only.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if condition covers a large area of the body.

OTC - WHEN USING SECTION

When using this product avoid contact with eyes.  If contact occurs, rinse eyes thoroughly with water.

OTC - STOP USE SECTION

Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.  If swallowed, get medical help or contact a poison control center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Read all package directions and warnings before use and use only as directed.
  • For best results, use at least two times per week or as recommended by a doctor.
  • Use on affected areas in place of regular soap or shampoo.
  • Wet skin and/or scalp.
  • Apply Psoriasin Therapeutic Shampoo and Body Wash and massage to form a rich lather.
  • Leave lather on the scalp for two minutes.
  • Rinse thoroughly.
  • Repeat if necessary.
  • Intended for use by normally healthy adults only.
  • Persons under 18 years of age or those with highly sensitive or allergic skin should use only as directed by a doctor.

Other information

INFORMATION FOR PATIENTS SECTION

Serious side effects associated with the use of this product may be reported to the phone number provided below.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Lauramidopropyl betaine, panthenol, phospholipid EFA, purified water, sodium chloride, sodium C14 - 16 olefin sulfonates.

OTC - QUESTIONS SECTION

Questions? 1-800-792-2582

Product Insert

SPL PATIENT PACKAGE INSERT SECTION

PSORIASIN Therapeutic Shampoo and Body Wash

3% Salicylic Acid

  • Relieves the symptoms of psoriasis, seborrheic dermatitis and related discomforts
  • Cleans, soothes and moisturizes

A WORD ABOUT PSORIASIN THERAPEUTIC SHAMPOO and BODY WASH

PSORIASIN Therapeutic Shampoo and Body Wash relieves the discomforts of psoriasis and seborrheic dermatitis. PSORIASIN Therapeutic Shampoo and Body Wash cleanses away scaling and flaking, relieves itching, redness and irritation on skin and scalp ... plus helps soothe and smooth skin and leave hair soft and manageable.

WHAT IS PSORIASIS AND SEBORRHEIC DERMATITIS?

PSORIASIS is a non-contagious skin disorder that afflicts millions of men and women of all ages. Normal skin cells multiply, mature and shed on a regular basis. In those ­afflicted with psoriasis, skin cells appear to multiply much faster than normal, with excessive skin cells accumulating on the skin surface. In its most common form, these cells form scaly, reddish patches which are often unsightly, uncomfortable and are frequently irritating, itchy and painful. While the exact causes of psoriasis are still unknown, it is reported that a susceptibility to psoriasis may be inherited ... passed along from one generation to another genetically within families. First visible outbreaks of psoriasis may be prompted by a stress such as surgery, a major infection, or a minor skin injury such as a burn or cut. After the first outbreak, psoriasis flare-ups tend to come and go without any specific regularity or frequency, although symptoms appear to diminish during warm summer months and increase during cold winter months. Some studies have shown a relationship between psoriasis flare-ups and periods of emotional stress.

The number of flare-ups and their intensity may differ from case to case. Although there is no known cure for psoriasis, the active ingredient in PSORIASIN Therapeutic Shampoo and Body Wash has been proven to help effectively relieve and control the symptoms of psoriasis, as well as prevent recurrences.

SEBORRHEIC DERMATITIS is a distinctly different condition, though sometimes it is confused with psoriasis. Seborrheic dermatitis is an inflammation affecting areas of the skin rich in sebaceous (oil producing) glands commonly on the hairy areas of the body, such as the scalp. This troublesome skin disorder tends to be marked by skin cell proliferation and heightened sebaceous gland activity ... skin cells shed and become scaly, itchy, red and irritated. Affected areas tend to display oily looking, yellowish, scaly patches. People who tend toward oily skin are more likely to be affected. While seborrheic dermatitis and psoriasis are different disorders, highly visible symptoms of seborrheic dermatitis, such as intense itching and dandruff respond well (as well as psoriasis symptoms) to the active ingredient in PSORIASIN. These symptoms can be relieved and controlled, as well as recurrences prevented, with regular use of PSORIASIN Therapeutic Shampoo and Body Wash.

HOW DO YOU KNOW IF YOU HAVE PSORIASIS OR SEBORRHEIC DERMATITIS OF THE SCALP OR BODY?

In its most common form, known as plaque psoriasis, the condition is characterized by sharply defined raised reddish areas of skin or patches, typically covered with overlapping, rough, dry silvery scaling. Often times outbreaks are accompanied by itching and flaking at the affected site. In many cases skin is cracked, irritated and burning. Seborrheic dermatitis frequently affects the scalp and other areas rich in sebaceous (oil producing) glands. Seborrheic dermatitis tends to show up as thick, greasy, yellowish scales, accompanied by itching and irritation.

If you experience any type of unusual skin eruption(s) including those described here, contact your doctor to make the correct diagnosis and obtain professional advice. You may wish to show him/her PSORIASIN Therapeutic Shampoo and Body Wash and discuss its use for relief and prevention.

ACTIVE INGREDIENT: Salicylic Acid 3%

USES: For the relief of symptoms associated with psoriasis and/or seborrheic dermatitis including itching, scaling, flaking, redness and irritation of the skin and scalp. Helps prevent recurrence.

WARNINGS: For external use only. Ask a doctor before use if condition covers a large area of the body. When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water. Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed. Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.

DIRECTIONS: • Read all package directions and warnings before use and use only as directed . • For best results, use at least two times per week or as recommended by a doctor .• Use on affected areas in place of regular soap or shampoo . • Wet skin and/or scalp . • Apply PSORIASIN Therapeutic Shampoo and Body Wash and massage to form a rich lather. • Leave lather on the scalp for two minutes. • Rinse thoroughly. • Repeat if necessary . • Intended for use by normally healthy adults only . • Persons under 18 years of age or those with highly sensitive or allergic skin should use only as directed by a doctor.

OTHER INFORMATION: Serious side effects associated with the use of this product may be reported to the phone number provided below.

INACTIVE INGREDIENTS: Lauramidopropyl Betaine, Panthenol, Phospholipid EFA, Purified Water, Sodium Chloride, Sodium C14-16 Olefin Sulfonate.

QUESTIONS: 1-800-792-2582

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Psoriasin Shampoo PDPPsoriasin Shampoo PDP

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1046281Psoriasin Therapeutic Shampoo & Body Wash 3 % Medicated Liquid SoapPSN2
1046277salicylic acid 3 % Medicated Liquid SoapPSN2
1046281salicylic acid 30 MG/ML Medicated Liquid Soap [Psoriasin Wash]SBD2
1046277salicylic acid 30 MG/ML Medicated Liquid SoapSCD2
1046281Psoriasin Therapeutic Shampoo & Body Wash 3 % Medicated Liquid SoapSY2
1046281Psoriasin Wash 30 MG/ML Medicated Liquid SoapSY2
1046277salicylic acid 3 % Medicated Liquid SoapSY2

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130072959710064GTIN-13: 0072959710064
EAN-13: 0072959710064
GTIN-12: 072959710064
UPC-A: 072959710064
GTIN storage (14 digits): 00072959710064
PsoriasinShampooPDP.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
52389-171-062020-01-31C16284748780-19d75b9d0-a93f-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
52389-171-06PsoriasinTherapeutic Shampoo and Body Wash185 g in 1 BOTTLE, PLASTICSHAMPOO1852

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
52389-171PSORIASIN THERAPEUTIC SHAMPOO AND BODY WASH (SALICYLIC ACID) SHAMPOO [ALVA-AMCO PHARMACAL COMPANIES, INC.]2Legacy NDC, 1 package rows20100507_3153a8b5-c027-4254-a61b-0c376a38d0f6.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Salicylic acidACTIVE INGREDIENTO414PZ4LPZ2
Salicylic acidACTIVE MOIETYO414PZ4LPZ2
Lauramidopropyl betaineINACTIVE INGREDIENT23D6XVI2332
Lecithin, soybeanINACTIVE INGREDIENT1DI56QDM622
PanthenolINACTIVE INGREDIENTWV9CM0O67Z2
Sodium C14-16 olefin sulfonateINACTIVE INGREDIENTO9W3D3YF5U2
Sodium chlorideINACTIVE INGREDIENT451W47IQ8X2
WaterINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
52389-17152389-171-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 141 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR24 mgExact identifier — unii candidate
134 equally ranked IID candidates
Lecithin, soybeanSOYBEAN LECITHIN1DI56QDM62CAPSULE / ORAL20 mgExact identifier — unii candidate
7 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR0.86 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / SUBCUTANEOUS1486 mgExact identifier — unii candidate
134 equally ranked IID candidates
Lecithin, soybeanSOYBEAN LECITHIN1DI56QDM62TABLET, EXTENDED RELEASE / ORAL20 mgExact identifier — unii candidate
7 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INFILTRATION3535 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XGEL / OPHTHALMIC0.9 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL1.35 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAVENOUS90 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XELIXIR / ORAL1 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS0.86 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Lecithin, soybeanSOYBEAN LECITHIN1DI56QDM62POWDER, FOR SUSPENSION / ORAL39 mgExact identifier — unii candidate
7 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / RECTALNAExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / SUBARACHNOID0.9 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRACARDIAC70 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XPOWDER, DENTIFRICE / DENTAL0.03 mg/mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRASYNOVIAL0.9 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / OPHTHALMIC13 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XLIQUID / NASAL7.4 mg/1mlExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / ENDOTRACHEAL68 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XCAPSULE / ORAL6 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRATHECAL9 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSUSPENSION / RESPIRATORY (INHALATION)43 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSUSPENSION / SUBCUTANEOUS0.8 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XTABLET, ORALLY DISINTEGRATING / ORAL10 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRAVITREAL10 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / IONTOPHORESIS0.6 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SUSPENSION / INTRASYNOVIAL4 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / EPIDURAL0.9 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUSNAExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSPRAY / NASAL30 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSUSPENSION / ORAL1126 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INTRA-ARTERIAL278 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INTRAVESICAL351 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / RETROBULBAR648 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XTABLET, DELAYED RELEASE / ORAL97 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAMUSCULAR90 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL11 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR226 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRATUMOR1.2 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XPOWDER, FOR SUSPENSION / ORAL98 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSUSPENSION / ENDOTRACHEAL7.6 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAOCULAR320 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XGEL / TOPICAL0.18 %w/wExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS0.68 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XLIQUID / INTRAMUSCULAR17 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / EPIDURAL648 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / EPIDURAL3535 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XGRANULE, FOR SUSPENSION / ORAL162 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XDROPS / NASALNAExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAVASCULARNAExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSHAMPOO / TOPICAL150 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / SUBCUTANEOUS90 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INTRAVENOUS2916 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSUSPENSION/ DROPS / OPHTHALMIC3 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / AURICULAR (OTIC)18 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INFILTRATION648 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / TOPICAL210 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XDROPS / OPHTHALMIC0.08 %w/wExact identifier — unii candidate
134 equally ranked IID candidates
Sodium chlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAPERITONEAL0.54 %w/vExact identifier — unii candidate
134 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a7138a76-0ec2-453c-9404-af6b8f4f1b5a3153a8b5-c027-4254-a61b-0c376a38d0f62010-05-07WarningsExact identifier
spl id: a7138a76-0ec2-453c-9404-af6b8f4f1b5a
spl set id: 3153a8b5-c027-4254-a61b-0c376a38d0f6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.